What is the size of the Global Oncolytic Virus Diagnostics Market?

The Global Oncolytic Virus Diagnostics Market was valued at USD 0.22 billion in 2023 and is projected to reach a market size of USD 1.17 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 27%.

What are the Global Oncolytic Virus Diagnostics Market drivers?

Advancements in diagnostic technologies and a growing focus on personalized cancer therapies are key drivers for the Global Oncolytic Virus Diagnostics Market.

What are the segments under the Global Oncolytic Virus Diagnostics Market By End Users?

The segments under the Global Oncolytic Virus Diagnostics Market By End Users include Hospitals, Diagnostic Centers, and Research Institutes..

Which is the most dominant region for the Global Oncolytic Virus Diagnostics Market?

North America is the most dominant region for the Global Oncolytic Virus Diagnostics Market.

Who are the leading players in the Global Oncolytic Virus Diagnostics Market?

The leading players in the Global Oncolytic Virus Diagnostics Market include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, and Bio-Rad Laboratories.